Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation

Journal of Cystic Fibrosis

Volumn 11, Issue 2, 2012, Pages 131-136

  Hofer, Markus ^a   Schmid, Christoph ^a   Benden, Christian ^a   Speich, Rudolf ^a   Inci, Ilhan ^a   Weder, Walter ^a   Boehler, Annette ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bronchiolitis obliterans syndrome; Cystic fibrosis; Diabetes mellitus; Lung transplantation

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGE; ARTICLE; BACTERIAL INFECTION; BODY MASS; BRONCHIOLITIS OBLITERANS; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FORCED EXPIRATORY VOLUME; GENE MUTATION; GLUCOSE BLOOD LEVEL; GRAFT INFECTION; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; BLOOD GLUCOSE; BRONCHIOLITIS OBLITERANS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LUNG TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858282244     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.10.005     Document Type: Article

References (30)

1. George P.M., Banya W., Pareek N., Bilton D., Cullinan P., Hodson M.E., et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ 2011, 342:d1008.
2. Ratjen F., Doring G. Cystic fibrosis. Lancet Feb. 22 2003, 361(9358):681-689.
3. Boehler A. Update on cystic fibrosis: selected aspects related to lung transplantation. Swiss Med Wkly Feb. 22 2003, 133(7-8):111-117.
4. Meachery G., De Soyza A., Nicholson A., Parry G., Hasan A., Tocewicz K., et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax Aug. 2008, 63(8):725-731.
5. Adler F.R., Aurora P., Barker D.H., Barr M.L., Blackwell L.S., Bosma O.H., et al. Lung transplantation for cystic fibrosis. Proc Am Thorac Soc Dec. 2009, 6(8):619-633.
6. Bradbury R.A., Shirkhedkar D., Glanville A.R., Campbell L.V. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an 'orphan' area? A retrospective case-control study. Intern Med J Jun. 2009, 39(6):384-388.
7. Mackie A.D., Thornton S.J., Edenborough F.P. Cystic fibrosis-related diabetes. Diabet Med Jun. 2003, 20(6):425-436.
8. McKone E.F., Emerson S.S., Edwards K.L., Aitken M.L. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet May 17 2003, 361(9370):1671-1676.
9. Moran A., Dunitz J., Nathan B., Saeed A., Holme B., Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care Sep. 2009, 32(9):1626-1631.
10. Hadjiliadis D., Madill J., Chaparro C., Tsang A., Waddell T.K., Singer L.G., et al. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clin Transplant Dec. 2005, 19(6):773-778.
11. Hofer M., Benden C., Inci I., Schmid C., Irani S., Speich R., et al. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant Apr. 2009, 28(4):334-339.
12. Liou T.G., Adler F.R., Fitzsimmons S.C., Cahill B.C., Hibbs J.R., Marshall B.C. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol Feb. 15 2001, 153(4):345-352.
13. Orens J.B., Estenne M., Arcasoy S., Conte J.V., Corris P., Egan J.J., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant Jul. 2006, 25(7):745-755.
14. Speich R., Nicod L.P., Aubert J.D., Spiliopoulos A., Wellinger J., Robert J.H., et al. Ten years of lung transplantation in Switzerland: results of the Swiss Lung Transplant Registry. Swiss Med Wkly Jan. 10 2004, 134(1-2):18-23.
15. Holzmann D., Speich R., Kaufmann T., Laube I., Russi E.W., Simmen D., et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation Jan. 15 2004, 77(1):134-136.
16. Estenne M., Maurer J.R., Boehler A., Egan J.J., Frost A., Hertz M., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant Mar. 2002, 21(3):297-310.
17. Moran A., Brunzell C., Cohen R.C., Katz M., Marshall B.C., Onady G., et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care Dec. 2010, 33(12):2697-2708.
18. Yousem S.A., Berry G.J., Cagle P.T., Chamberlain D., Husain A.N., Hruban R.H., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant Jan. 1996, 15(1 Pt 1):1-15.
19. Bismuth E., Laborde K., Taupin P., Velho G., Ribault V., Jennane F., et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr Apr. 2008, 152(4):540-545. 5 e1.
20. Milla C.E., Billings J., Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care Sep. 2005, 28(9):2141-2144.
21. Marshall B.C., Butler S.M., Stoddard M., Moran A.M., Liou T.G., Morgan W.J. Epidemiology of cystic fibrosis-related diabetes. J Pediatr May 2005, 146(5):681-687.
22. Vizza C.D., Yusen R.D., Lynch J.P., Fedele F., Alexander Patterson G., Trulock E.P. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med Sep. 2000, 162(3 Pt 1):819-825.
23. Chamnan P., Shine B.S., Haworth C.S., Bilton D., Adler A.I. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care Feb. 2010, 33(2):311-316.
24. Preumont V., Hermans M.P., Lebecque P., Buysschaert M. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation. Diabetes Care May. 2007, 30(5):1187-1192.
25. Kerem E., Corey M., Kerem B.S., Rommens J., Markiewicz D., Levison H., et al. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). N Engl J Med Nov. 29 1990, 323(22):1517-1522.
26. Koch C., Rainisio M., Madessani U., Harms H.K., Hodson M.E., Mastella G., et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol Nov. 2001, 32(5):343-350.
27. Chmiel C., Speich R., Hofer M., Michel D., Mertens T., Weder W., et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis Mar. 15 2008, 46(6):831-839.
28. McManus T.E., Milne D.G., Whyte K.F., Wilsher M.L. Exudative bronchiolitis after lung transplantation. J Heart Lung Transplant Mar. 2008, 27(3):276-281.
29. Moran A., Pekow P., Grover P., Zorn M., Slovis B., Pilewski J., et al. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care Oct. 2009, 32(10):1783-1788.
30. Nathan B., Moran A. Treatment recommendations for cystic fibrosis-related diabetes: too little, too late?. Thorax Jul. 2011, 66(7):555-556.